Hints and tips:
Showing results for Bayer Crop Science Inc.
Related Special Reports
...German drugs and crop science conglomerate Bayer has postponed a decision on whether to break itself up, as it launches a €2bn cost-cutting plan and promises to bring down debt....
...Bayer is under pressure from shareholders as it is reeling from the $63bn acquisition of US crop science giant Monsanto....
...He added that the underlying operative problems in the pharma and crop science businesses needed to be addressed without undue job cuts....
...The company, which has been under pressure from investors to break itself up, is still struggling with the damage from its $63bn takeover of US crop sciences group Monsanto in 2016....
...Despite that, the company has taken steps to end the protracted crisis over Roundup, which Bayer acquired as part of its ill-fated $63bn acquisition of US crop sciences business Monsanto in 2016....
...from the crop sciences business....
...Bayer also took a €4bn impairment charge on the value of its crop science assets, adding to a €2.3bn writedown in the second quarter....
...Activist investors want to split the group’s pharmaceuticals business from its crop science unit to optimise its valuation....
...Crop science is the largest part of the business and would work as a standalone. There is also a case for splitting off pharma, which would be worth about €33bn....
...Last month he blasted Bayer’s performance as “unacceptable” and stressed that “all options” were on the table, including splitting the pharma unit from the crop science division....
...Bayer has argued that cash flow from crop science and its consumer health unit help fund its growing pharmaceuticals pipeline....
...Some investors fear that the uncertainty over Roundup’s financial burden could limit Anderson’s room for manoeuvre with regard to a potential separation of Bayer’s crop science business and its pharma unit...
...Henry adds that better soil health as a result of regenerative practices, also make crops more resilient to extreme weather events....
...In the science fiction movie, the scientists aboard a spaceship gradually find out that the computer had taken over the mission....
...AstraZeneca said in February it had chosen to open a $360mn factory in Ireland, rather than in the UK, because of a “discouraging tax rate”, while German drugmaker Bayer said last year that it had cut staff...
...It argues that this would send a “strong signal of discontinuity” for the underperforming company, which should be split into its crop science and pharmaceutical divisions....
...Biotech beauty products are increasingly filling our bathroom cabinets; the science may have been used in a simple way for decades, but new innovations are driving considerable change....
...Clements thinks life science companies will bounce back next year, and is hopeful about electric vehicles and water stocks....
...Matthias Berninger, Bayer’s head of science and sustainability and a former politician with the German Green party, said the council has worked to improve the group’s ESG policies and wants to pioneer green...
...Bayer has about €120bn in assets. If Bayer’s crop sciences division were to trade on its own, he said, it could have a valuation similar to Corteva’s....
...Analysts, investment bankers and activist shareholders have long argued in favour of a break-up of the German conglomerate whose two main divisions pharmaceuticals and crop science have few synergies....
...Adjusted sales in the first nine months were up almost 17 per cent over the previous year in Bayer’s crop science division....
...science....
...“A lot of the work that needs to be done to ‘green’ Bayer’s crop sciences business isn’t necessarily through changing the business itself, it’s through changing the perception thereof.”...
...Ear for the long haul Crop science is also attracting greater political and investor attention....
International Edition